To confirm that sensitization of the tumor cells to doxorubicin by propranolol occurs through a β-AR-independent mechanism, we treated COSB cells with the S-(−) and R-(+) enantiomers of propranolol, or a reconstituted racemic mixture of the enantiomers. Here, ADRB2 is linked to neoplasm.